Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Standard
Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves. / Tarantini, Giuseppe; Sathananthan, Janarthanan; Fabris, Tommaso; Landes, Uri; Bapat, Vinayak N.; Khan, Jaffar M.; Nai Fovino, Luca; Zaid, Syed; Van Mieghem, Nicolas M.; Latib, Azeem; Waksman, Ron; De Backer, Ole; Rogers, Toby; Søndergaard, Lars; Tang, Gilbert H.L.
I: JACC: Cardiovascular Interventions, Bind 15, Nr. 18, 2022, s. 1777-1793.Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves
AU - Tarantini, Giuseppe
AU - Sathananthan, Janarthanan
AU - Fabris, Tommaso
AU - Landes, Uri
AU - Bapat, Vinayak N.
AU - Khan, Jaffar M.
AU - Nai Fovino, Luca
AU - Zaid, Syed
AU - Van Mieghem, Nicolas M.
AU - Latib, Azeem
AU - Waksman, Ron
AU - De Backer, Ole
AU - Rogers, Toby
AU - Søndergaard, Lars
AU - Tang, Gilbert H.L.
N1 - Publisher Copyright: © 2022 American College of Cardiology Foundation
PY - 2022
Y1 - 2022
N2 - Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients. Given the longer life expectancy of these patients, the bioprosthetic valve will eventually fail, and aortic valve reintervention may be necessary. Although currently rare, redo-TAVR will likely increase in the future as younger patients are expected to outlive their transcatheter bioprosthesis. This review provides a contemporary overview of the indications, procedural planning, implantation technique, and outcomes of TAVR in failed transcatheter bioprosthetic aortic valves.
AB - Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients. Given the longer life expectancy of these patients, the bioprosthetic valve will eventually fail, and aortic valve reintervention may be necessary. Although currently rare, redo-TAVR will likely increase in the future as younger patients are expected to outlive their transcatheter bioprosthesis. This review provides a contemporary overview of the indications, procedural planning, implantation technique, and outcomes of TAVR in failed transcatheter bioprosthetic aortic valves.
KW - redo-TAVR
KW - transcatheter heart valve
KW - valve in valve
U2 - 10.1016/j.jcin.2022.07.035
DO - 10.1016/j.jcin.2022.07.035
M3 - Review
C2 - 36137681
AN - SCOPUS:85137652922
VL - 15
SP - 1777
EP - 1793
JO - J A C C: Cardiovascular Interventions
JF - J A C C: Cardiovascular Interventions
SN - 1936-8798
IS - 18
ER -
ID: 327320882